Viking Therapeutics Inc
SWB:1VT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Viking Therapeutics Inc
SWB:1VT
|
US |
|
L
|
Ladder Capital Corp
F:LD1A
|
US |
|
E
|
EOG Resources Inc
F:EO5
|
US |
|
L
|
Lincoln National Corp
DUS:LCO
|
US |
|
A
|
AECOM
F:E6Z
|
US |
|
K
|
Klepierre SA
SWB:KPR
|
FR |
|
Harvey Norman Holdings Ltd
OTC:HNORF
|
AU |
|
F
|
Fujikura Ltd
DUS:FJK
|
JP |
|
Sumitomo Corp
TSE:8053
|
JP |
|
K
|
Kraft Heinz Co
BMV:KHC
|
US |
|
C
|
Carlsberg A/S
SWB:CBGB
|
DK |
|
TAL Education Group
NYSE:TAL
|
CN |
|
T
|
Thoresen Thai Agencies PCL
SET:TTA
|
TH |
|
M
|
Morgan Stanley
SWB:DWD
|
US |
|
T
|
Thai Reinsurance PCL
SET:THRE
|
TH |
|
C
|
Coca-Cola Europacific Partners PLC
F:CK0
|
UK |
Bankruptcy Probability
Viking Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Viking Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Viking Therapeutics Inc
NASDAQ:VKTX
|
3.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
467.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
212.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
186.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
129.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
69B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
86.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
53.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Viking Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Viking Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.